Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Serruys, P.W
Right arrow Articles by Aoki, J
Right arrow Search for Related Content
PubMed
Right arrow Articles by Serruys, P.W
Right arrow Articles by Aoki, J
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The European Society of Cardiology

Therapeutic options for patients with chronic myocardial ischaemia

P.W Serruys* and J Aoki

Department of Interventional Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands

* P.W. Serruys, Department of Interventional Cardiology, Thoraxcenter Bd 406, Dr. Molewaterplein 40, Erasmus MC, NL-3015GD Rotterdam, The Netherlands. Tel.: +31-10-4635-260; fax: +31-10-4369-154
p.w.j.c.serruys{at}erasmusmc.nl

Abstract

Coronary heart disease (CHD) is a leading cause of death and disability worldwide. Chronic myocardial ischaemia resulting from CHD can cause stable angina and interfere with ordinary activities. Numerous approaches for reducing myocardial ischaemia are currently available. These include lifestyle changes such as weight reduction, exercise, smoking cessation and reduced consumption of salt and fat; pharmacological approaches such as use of anti-platelet agents, statins, angiotensin converting enzyme inhibitors, ß-blockers, calcium channel blockers and nitrates; surgical revascularization approaches such as coronary artery bypass grafting and percutaneous methods (balloon angioplasty, bare-metal stents, drug eluting stents). Alternative methods for reducing anginal pain such as external enhanced counterpulsation and spinal cord stimulation are also available. Despite this wide range of choices, patients with ischaemic heart disease usually require a combination of these therapies, and may continue to experience symptoms. While traditional therapies continue to be improved, strategies to increase myocardial circulation by stimulating formation of collateral vessels around obstructed coronary arteries are also in development. These approaches include therapy with recombinant growth factor proteins, transfer of growth factor genes and stem cell therapy. It is hoped that at least one of these approaches will safely and effectively reduce myocardial ischaemia, providing a new option for patients with CHD.

Key Words: Coronary heart disease • Myocardial ischaemia • Chronic stable angina • Prevention • Treatment


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.